Should Shares CRISPR Therapeutics Be a February Pick?
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
BTC has broader recognition and acceptance in stores and wallets, while ETH benefits from a thriving developer ecosystem. This look compares adoption levels.
27,847 articlesBiotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
A notable hedge fund just put $20 million into BlackLine. Is this the spark a turnaround scenario needs, or a cautiou...
Oneok beat quarterly expectations but issued soft 2026 guidance, sending shares lower. This article explains why oneo...
CoreCivic has faced a share-price headwind even as revenue climbs. A notable $5 million stake by Hahn Capital signals...
A major fund reported a sizeable exit from an offshore energy stake, triggering a review of how investors manage risk...
Water security has become the defining risk in the Iran war, shifting attention from oil to desalination infrastructu...
Robinhood unveils a private-market fund designed for everyday investors to back late-stage startups, signaling a shif...
Prediction markets grabbed headlines, but the real long-term payoff in tech comes from AI stocks. This guide explains...
El Pollo Loco shares surged after a solid earnings beat and improving store momentum. This article breaks down the re...
Money stories outlive bank balances. Learn to tell yours clearly, protect loved ones, and build a legacy that reflect...
Could 2026 bring a surprise policy pivot? This guide explains why the Fed might hike instead of cutting, how that sce...
Goldman Sachs sets COIN target at $235, signaling renewed confidence in Coinbase as crypto markets stabilize and inst...